Gene · 4507
Papers2,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Factors predictive of progression in lesions categorised as well-differentiated papillary mesothelial tumour of the pleura, tunica vaginalis and peritoneum: a scoping review. | Cancer Treat Res Commun | 2026 | 41690006 | PubTator, text mining | PubMed |
| Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung Cancer. | bioRxiv | 2026 | 41648424 | PubTator, text mining | PubMed |
| Prognostic Significance of Abnormal MTAP and p16 Expression in Gastrointestinal Stromal Tumors (GISTs). | Appl Immunohistochem Mol Morphol | 2026 | 41634534 | PubTator, text mining | PubMed |
| Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment. | Elife | 2026 | 41632514 | PubTator, text mining | PubMed |
| The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis. | Int J Mol Sci | 2026 | 41596618 | PubTator, text mining | PubMed |
| Metastatic and recurrent salivary gland carcinoma: clinical characteristics and comprehensive molecular profiling at a tertiary care center. | J Cancer Res Clin Oncol | 2026 | 41593390 | PubTator, text mining | PubMed |
| FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Acta Neuropathol | 2026 | 41591566 | PubTator, text mining | PubMed |
| Mesothelial Lesions of the Testis: A Review. | Adv Anat Pathol | 2026 | 41582881 | PubTator, text mining | PubMed |
| Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data. | JCO Precis Oncol | 2026 | 41576306 | PubTator, text mining | PubMed |
| Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategies. | Gynecol Oncol Rep | 2026 | 41567617 | PubTator, text mining | PubMed |
| Methionine restriction for cancer therapy: From preclinical studies to clinical trials. | Cancer Pathog Ther | 2026 | 41550357 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning-based QSAR and molecular modelling. | Mol Divers | 2026 | 41533017 | PubTator, text mining | PubMed |
| Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer. | J Med Chem | 2026 | 41527338 | PubTator, text mining | PubMed |
| Utility of p53, p16, and MTAP Immunohistochemistry in Oral Epithelial Dysplasia With Concurrent Candidiasis: A Novel Pattern-based Approach. | Mod Pathol | 2026 | 41521009 | PubTator, text mining | PubMed |
| MTAP IHC on the Map: Toward a New Predictive Biomarker in NSCLC. | J Thorac Oncol | 2026 | 41519529 | PubTator, text mining | PubMed |
| MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario. | Cancer Res | 2026 | 41512197 | PubTator, text mining | PubMed |
| Targeting of CDK1 and PRMT5 as a potential therapeutic combination for non-small cell lung cancer. | Histol Histopathol | 2026 | 41487038 | PubTator, text mining | PubMed |
| Learned Conformational Space and Pharmacophore Into Molecular Foundational Model. | Adv Sci (Weinh) | 2026 | 41486619 | PubTator, text mining | PubMed |
| Significance and Utility of Immunohistochemical MTAP Expression to Predict CDKN2A Genomic Status in Diffuse Large B-Cell Lymphoma. | Pathol Int | 2026 | 41410267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4507/papers?page=8